Intratio
Quantitative Research
Skip to main content
AI Market Summary
Loading market intelligence...
  • Sign in
    My account
    Logout
AI 90-DAY FORECAST
NEUTRAL SIGNAL
██.█% Sign up free to reveal

Neuroone Medical Technologies Corp (NMTC) AI Forecast

Our AI analyzed Neuroone Medical Technologies Corp. Create a free account and follow it to see the 90-day price prediction.

✓ Free account • ✓ 30-day free trial

$NMTC Neutral Signal Full forecast available
Sign Up Free

Neuroone Medical Technologies Corp (NMTC) Stock Forecast 2025

Neuroone Medical Technologies Corp (NMTC) AI Stock Price Forecast & Investment Analysis

Neuroone Medical Technologies Corp Stock Price Chart and Technical Analysis

Loading chart...

Neuroone Medical Technologies Corp (NMTC) - Comprehensive Stock Analysis & Investment Research

Deep dive into Neuroone Medical Technologies Corp's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Analysis updated on July 28, 2026, 8:31 a.m. (UTC)

Neuroone Medical Technologies Corp Investment Summary

When evaluating whether Neuroone Medical Technologies Corp (NMTC) represents a compelling investment opportunity, investors must consider multiple factors including the company's financial health, market position, growth prospects, and what our AI-powered predictive models suggest about its near-term price trajectory.

Company Profile

Neuroone Medical Technologies Corp (NMTC) operates within the Industrial Applications and Services sector, specifically in the Surgical & Medical Instruments & Apparatus industry. . With a market capitalization of $16 million, the company is a small-cap stock that may offer higher growth potential but also carries higher volatility.

Financial Performance Analysis

Our comprehensive financial analysis covers Neuroone Medical Technologies Corp's revenue, profitability metrics, balance sheet strength, and cash flow generation...

AI Price Predictions

Get AI-powered 7-day, 30-day and 90-day price forecasts for Neuroone Medical Technologies Corp along with confidence scores and detailed analysis...

Investment Considerations

Expert analysis of whether Neuroone Medical Technologies Corp is suitable for your investment objectives, risk tolerance, and time horizon...

Continue Reading Full Analysis

Get the complete investment breakdown for Neuroone Medical Technologies Corp

Sign Up Free
Corporate Identity

Neuroone Medical Technologies Corp (Stock Symbol: NMTC) is a prominent company operating within the Industrial Applications and Services sector, with a specific focus on the Surgical & Medical Instruments & Apparatus industry. The company's shares are publicly traded on the Nasdaq exchange.

Leadership & Workforce

Detailed information about Neuroone Medical Technologies Corp's leadership team, workforce size, and organizational structure...

Market Classification

Market capitalization analysis and stock classification (mega-cap, large-cap, mid-cap, small-cap) for Neuroone Medical Technologies Corp...

Sector & Industry Analysis

In-depth sector dynamics and industry context for Neuroone Medical Technologies Corp...

Unlock Full Company Profile

Get complete details about Neuroone Medical Technologies Corp

Sign Up Free
Revenue & Growth Analysis

Neuroone Medical Technologies Corp generates annual revenues of $9 million , representing an emerging company in its growth phase.

Profitability Metrics

Net profit margin, gross margin, and operating margin analysis for Neuroone Medical Technologies Corp...

Market Valuation

P/E ratio, price-to-book, and valuation multiples for Neuroone Medical Technologies Corp...

Return Metrics

Return on equity (ROE), return on assets (ROA), and capital efficiency for Neuroone Medical Technologies Corp...

Unlock Financial Analysis

Get complete financial metrics for Neuroone Medical Technologies Corp

Sign Up Free
AI ANALYSIS AVAILABLE

Unlock Neuroone Medical Technologies Corp's AI Price Forecast

Join 10,000+ investors using our 67%+ accurate AI predictions

4,000+ Stocks Analyzed
67%+ Accuracy Rate
Daily Updates
Start 30-Day Free Trial →

✓ 30-day free trial • ✓ Cancel anytime

Strategic Market Position

Neuroone Medical Technologies Corp strategically competes in the highly dynamic Surgical & Medical Instruments & Apparatus marketplace. As a small-cap company, it represents an emerging market participant with potentially significant growth opportunities. Small-caps often offer greater growth potential as they capture market share and scale their operations, though this comes with higher risk and volatility. Success at this stage can lead to substantial returns for early investors who identify winning business models.

Industry Competitive Landscape

Neuroone Medical Technologies Corp competes within the Industrial Applications and Services sector, navigating the competitive dynamics and market forces specific to this industry. The company's competitive position depends on its ability to differentiate through product quality, cost efficiency, customer relationships, or other strategic advantages relevant to its specific market segment.

Operational Efficiency

The company currently shows negative free cash flow of $-8 million . Negative free cash flow may reflect heavy investment in growth, working capital needs, or operational challenges. This is common for high-growth companies investing aggressively but warrants attention for mature businesses.

Asset Utilization Efficiency

Asset turnover ratio of 1.28x indicates solid asset utilization efficiency appropriate for many manufacturing or mixed business models. This level suggests the company generates meaningful revenue from its asset base while maintaining necessary capital investments for operations.

Financial Strength & Leverage

Current ratio of 4.21 demonstrates strong short-term liquidity with current assets significantly exceeding current liabilities. This provides a substantial buffer for meeting near-term obligations and handling unexpected financial needs.

Neuroone Medical Technologies Corp (NMTC) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Neuroone Medical Technologies Corp stock analysis.

Deep dive into Neuroone Medical Technologies Corp's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Neuroone Medical Technologies Corp stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Neuroone Medical Technologies Corp:

P/B Ratio 3.14x
Market Cap $16M
EPS $-0.02
Book Value/Share $0.59
Revenue/Share $1.13
FCF/Share $-0.88
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Neuroone Medical Technologies Corp converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Neuroone Medical Technologies Corp: An ROE of -1.3% indicates room for improvement in shareholder value creation.

ROE -1.3%
ROA -0.9%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Neuroone Medical Technologies Corp's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Neuroone Medical Technologies Corp: A current ratio of 4.21 indicates strong liquidity.

Current Ratio 4.21x
Quick Ratio 2.96x
D/E Ratio 0.49x
Financial Leverage 1.49x
Interest Coverage -433.0x
Working Capital $5M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Neuroone Medical Technologies Corp's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Neuroone Medical Technologies Corp: Free cash flow of $-8M indicates cash challenges that need attention.

Operating Cash Flow -$50K
Free Cash Flow -$8M
Capital Spending -$8M
FCF/Sales -78.1%
CapEx/Sales 77.6%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Neuroone Medical Technologies Corp uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Neuroone Medical Technologies Corp: An asset turnover of 1.28x demonstrates efficient asset utilization.

Asset Turnover 1.28x
Receivables Turnover 5.1x
Fixed Assets Turnover 42.2x
Days Sales Outstanding 71 days
Understanding Financial Statement Data

What these metrics mean: Key figures from Neuroone Medical Technologies Corp's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Neuroone Medical Technologies Corp: With annual revenue of $9M, Neuroone Medical Technologies Corp represents a smaller but potentially high-growth operation.

Income Statement
Total Revenue $9M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 7%
Cash & Short-term Investments 3%
Total Liabilities 2%
Short-term Debt 1%
Accounts Receivable 2%
Inventory 2%
Dividend & Shareholder Information
Shares Outstanding 9M
Growth Metrics (YoY)
EPS Growth -0.9%

Latest Neuroone Medical Technologies Corp Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Neuroone Medical Technologies Corp (NMTC) stock price and investment outlook.

📰 Loading...

Neuroone Medical Technologies Corp Competitors & Peer Analysis - Industrial Applications and Services Sector

Comparative analysis of Neuroone Medical Technologies Corp against industry peers and competitors in the Industrial Applications and Services sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
ADGM ██% $11M x 1.9x
AEMD ██% $1M x 0.3x
ALUR ██% $6M x x
AMIX ██% $2M x 0.3x
ANGO ██% $570M x 3.3x
ANIK ██% $201M x 1.5x
AORT ██% $1.25B 107.3x 2.8x
APYX ██% $163M x 12.7x
ARAY ██% $27M x 0.6x
ATEC ██% $1.33B x x
ATRC ██% $1.90B 182.0x 3.7x
AURX ██% $49M x x
BAX ██% $12.02B x 2.0x
BBNX ██% $713M x 2.6x
BDX ██% $43.79B 38.5x 1.8x
BEAT ██% $29M x 45.9x
BJDX ██% $1M x 0.3x
BSX ██% $67.58B 19.0x 2.6x
BTCY ██% $2M x x
BVS ██% $838M 29.4x 4.4x
BWAY ██% $632M x x
CARL ██% $311M x 3.4x
CERS ██% $596M x 8.8x
CLPT ██% $438M x 23.2x
CODX ██% $7M x 0.5x
CTSO ██% $23M x 10.3x
CVRX ██% $129M x 4.4x
DCTH ██% $412M 733.5x 3.7x
DRIO ██% $55M x 0.9x
DRTS ██% $1.07B x 13.9x
DXCM ██% $28.31B 30.4x 9.6x
EBRCZ ██% $137M x 14.4x
EMBC ██% $204M 1.8x x
FEMY ██% $9M x 1.3x
FOFA ██% $27M 173.9x 28.2x
GCTK ██% $2M x x
GIPL ██% $170K x 0.3x
GKOS ██% $8.87B x 13.2x
GMED ██% $10.59B 18.1x 2.2x
GUTS ██% $127M x 6.0x
HAE ██% $3.62B 37.2x 4.5x
HRGN ██% $18M x 200.7x
HTFL ██% $2.18B x 7.7x
IART ██% $1.50B x 1.4x
ICCM ██% $10M x 1.1x
ICUI ██% $4.04B 87.1x 1.9x
IDXG ██% $43M 1.8x 1.9x
INBS ██% $4M x 0.5x
INSP ██% $1.47B 11.2x 1.9x
IRMD ██% $1.22B 51.5x 12.3x
IRTC ██% $3.68B x 22.9x
IVF ██% $2M x 0.1x
KIDS ██% $469M x 1.4x
KMTS ██% $1.33B x 5.1x
KRMD ██% $188M x 11.1x
LMAT ██% $2.26B 36.2x 5.6x
LNSR ██% $65M 2.2x 6.0x
LUCD ██% $172M x 43.1x
LUNG ██% $52M x 1.1x
LYRA ██% $920K x x
MBOT ██% $118M x 1.6x
MCAG ██% $37M x x
MDAI ██% $52M x x
MDLN ██% $70.74B 84.5x 6.3x
MDNC ██% $59M 65.1x 10.0x
MDXG ██% $634M 20.7x 2.6x
MMED ██% $4.59B x 1.3x
MMM ██% $87.46B 29.2x 29.6x
MMSI ██% $4.54B 32.6x 2.8x
MODD ██% $12M x 1.0x
NEPH ██% $41M 52.7x 3.8x
NMTC ██% $16M x 3.1x
NPCE ██% $498M x 34.4x
NSPR ██% $32M x 0.7x
NUMD ██% $2M x x
NVCR ██% $2.32B x 6.9x
NVNO ██% $7M x 0.3x
NXGL ██% $4M x 1.0x
NYXH ██% $147M x x
OBIO ██% $213M x 5.2x
ODYY ██% $710K x x
OFIX ██% $443M x 1.0x
OSRH ██% $15M x 0.1x
OSUR ██% $280M x 0.9x
PAVM ██% $32M x 0.8x
PDEX ██% $175M 14.6x 3.9x
PEN ██% $12.49B 73.0x 8.5x
PETV ██% $25M x 11.4x
PFSA ██% $930K x x
PLRZ ██% $29M x 1.1x
PLSE ██% $2.11B x 31.9x
PMI ██% $9M x 2.4x
PODD ██% $11.08B 36.6x 8.5x
PRCT ██% $999M x 2.9x
PREM ██% $2M x 0.6x
PROF ██% $249M x 4.2x
PSTV ██% $26M x 2.2x
PYPD ██% $77M x 7.0x
QTEX ██% $49M x 21.3x
RCEL ██% $142M x x
RDGL ██% $29M x 10.7x
RMD ██% $27.83B 18.3x 4.3x
RTGN ██% $75M x x
RVP ██% $20M x 0.3x
SGHT ██% $254M x 4.7x
SGP ██% $698M x 2.8x
SIBN ██% $728M x 4.1x
SIGY ██% $160K x x
SINT ██% $9M x 10.2x
SKIN ██% $95M x 1.7x
SNOA ██% $6M x 1.8x
SNWV ██% $51M 3.2x 27.7x
SOLV ██% $13.85B 9.7x 2.8x
SRTS ██% $50M x 1.1x
SSII ██% $681M x 12.5x
SSKN ██% $0.00M x 0.0x
STIM ██% $121M x 9.1x
STME ██% $6M x x
STVN ██% $5.45B x x
SYK ██% $129.82B 38.9x 5.7x
TCMD ██% $635M 31.3x 2.9x
TELA ██% $27M x x
TFX ██% $5.91B x 1.9x
TLSI ██% $267M x 20.8x
TMCI ██% $258M x 3.4x
TNDM ██% $1.15B x 8.7x
TNON ██% $3M x 1.7x
UFPT ██% $1.89B 27.5x 4.3x
USAQ ██% $5M 10.4x 3.0x
UTMD ██% $217M 20.0x 1.8x
VTAK ██% $1M x 0.1x
VVOS ██% $6M x x
VYCO ██% $2M x x
WST ██% $23.20B 41.1x 7.8x
XAIR ██% $4M x 0.6x
XTNT ██% $60M 33.0x 1.2x
Reveal all forecasts See exact % predictions for all competitors
Sign up free

Frequently Asked Questions - Neuroone Medical Technologies Corp Stock Forecast

How accurate are Neuroone Medical Technologies Corp stock predictions?

Our AI model shows a 5% Spearman correlation coefficient for NMTC predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence Neuroone Medical Technologies Corp stock price forecasts?

Our analysis considers Neuroone Medical Technologies Corp's financial metrics, Industrial Applications and Services sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Neuroone Medical Technologies Corp a good investment in 2025?

Based on our AI analysis, Neuroone Medical Technologies Corp shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Neuroone Medical Technologies Corp forecasts updated?

Neuroone Medical Technologies Corp stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want a simpler view of Neuroone Medical Technologies Corp?

View simplified analysis on AI Stock Finder →

My Portfolio

Investment Dashboard

Loading your portfolio...